Toroudi Hamidreza Pazooki, Borghei Razavi Mohammad, Borghei Razavi Hamid, Tabatabayi Reza Mostafavi, Tabar Yaser Tolouei, Yahyavi Seyyed Taha, Montazer Mehdi
Department of Physiology, IRAN University of Medical Science, Iran.
Neurol India. 2009 May-Jun;57(3):305-9. doi: 10.4103/0028-3886.53292.
Pain management is an important component in the postoperative period following discectomy.
We hypothesized that mesalamine considering its better safety profile, is likely to be a better choice, if it would be as effective as ibuprofen in controlling post-discectomy pain.
A double-blind randomized controlled trial was performed on patients who underwent lumbar discectomy surgery.
Of the 58 patients who had lumbar discectomy, 27 patients were randomized to oral ibuprofen 500 mg and 31 patients to mesalamine 400 mg, three times a day for nine days following surgery. There was no placebo group. Severity of pain was assessed by using 10- cm visual analogue scale (VAS), once before operation and for nine days after.
Mean +/- SD pain scores were compared between groups and the statistical difference was estimated by Student's test using SPSS (Version 13). We also calculated the power of each t-test. Repeated measure ANOVA was performed for measuring the effect of time.
The age range of the patients was 35 to 60 years (mean: 42.2 years). Mean +/- SD preoperative pain scores for ibuprofen or mesalamine-treated groups were 7.852 +/- 2.441 and 7.806 +/- 2.892, respectively. At the end of day 9, mean +/- SD of pain score was 2.704 +/- 2.284 and 2.717 +/- 2.273 for ibuprofen and mesalamine-treated groups respectively. Both drugs significantly reduced postoperative pain and there was no statistically significant difference between the two groups.
Since both drugs showed almost equal analgesic effect, considering its safety profile mesalamine, seems to be the preferred choice to alleviate post-discectomy surgery pain.
疼痛管理是椎间盘切除术后恢复期的一个重要组成部分。
我们假设,考虑到美沙拉嗪具有更好的安全性,如果它在控制椎间盘切除术后疼痛方面与布洛芬效果相同,那么它可能是一个更好的选择。
对接受腰椎间盘切除术的患者进行了一项双盲随机对照试验。
在58例行腰椎间盘切除术的患者中,27例患者被随机分配口服500毫克布洛芬,31例患者被随机分配口服400毫克美沙拉嗪,术后每天三次,共九天。没有安慰剂组。通过使用10厘米视觉模拟量表(VAS)评估疼痛严重程度,术前评估一次,术后九天每天评估一次。
比较两组的平均±标准差疼痛评分,并使用SPSS(版本13)通过学生检验估计统计学差异。我们还计算了每个t检验的效能。进行重复测量方差分析以测量时间的影响。
患者年龄范围为35至60岁(平均:42.2岁)。布洛芬或美沙拉嗪治疗组术前平均±标准差疼痛评分分别为7.852±2.441和7.806±2.892。在第9天结束时,布洛芬和美沙拉嗪治疗组的疼痛评分平均±标准差分别为2.704±2.284和2.717±2.273。两种药物均显著减轻了术后疼痛,两组之间无统计学显著差异。
由于两种药物显示出几乎相同的镇痛效果,考虑到美沙拉嗪的安全性,它似乎是缓解椎间盘切除术后疼痛的首选药物。